joining us to discuss the stories are scott schaeffer, senior editor of california politics and government. republican political consult nt shawnlsh of wilson walsh consulting and jill tucker,"s francisco chronicle" education reporter. welcome to you all. >> thank you. >> jill, the cnlege admiss scandal has roots here in northern california. the bribes, many were funneled through a foundation based in sacramento. can you tell us what happened with the $20 million that that foundation took in? where did it go? >> $25 million. it not toward nonprofit good will and programs for underprivileged kids as thet nonproclaimed. it actually went to funnel to coaches andop other p at universities to helpealthy and actresses, doctors, ceos,ret thids into the college of thir choice. you looked through the tax documents. oneth said made donations to friends of cambodia. >> yes. and we never heard of these eople. we certainly have never gotten a dime. so far, we haven't identified really any of the money funneling toward charitable cau causes or helping disadvantaged youth. it seems that all that money he

jill tuck we the "san francisco chronicle," scott schaeffer with the k community and also shawn walsh, thank you for being here. >> thank you. >>> now tocs local poli on monday, san francisco mayor appointed someone to serve as san francisco next public defender. he will replace hadachi who held the office since 2003 until his abrupt death last month at age 59. he has beenith the public defender's office for 11 years and had been managing his felony division. in a restatement, mayor praised him for his commitment to justice and equity and for continuing adachi's legacy. nice to you have here. >> thank you for having me. >> congratulations on your new position. how are you feeling? >> it's a lot in a short amount of time.bu the office has really been wonderful in their support of me andon direcng and continuing his legacy and expanding on it. a lot of vee community h been really positive about this development. i'm excited to move in a newec dion. >> and what was that new direction? what is the priorities? >> well, what is a new direction? jeff was someone who was always believed in a

scott gottlieb can -- discussions -- discusses tenure and the future of the fda. from the brookings institution, this is about an hour. brookings schaeffer institute for health policy, a name not chosen for brevity, i would like to welcome everyone here. scott's biography is so long i had to write down, i he is 46 years old. he has been a financial analyst, a think take fellow, a drug company consultant and director. he has done three separate stints at the fda, first as an assistant and then as a director for scientific affairs. and he is also a cancer survivor, and sometime along the way he managed to have three kids did it efficiently because two of them are twins. i think -- >> my wife did it efficiently. david: i think the thing has most intrigued me about scott i waseb's tenure is that looking at what people said when he was appointed, and one of the milder comments was that he is a shell for pharmaceutical corporations, and i think he has impressed everybody, even people who do not agree with him with integrity that he has shown as fda commissioner and the ability to manage a large bureaucracy and the fact that he has gotten so mu

and thef of our center brookings schaeffer institute for health policy, a name not chosen for brevity, i would like to welcome everyone here. scott's biography is so long i had to write down, it is hard to believe he's only 46 years old because he has done the following things. a financial analyst, a practicing physician, a think tank fellow with a venture capitalist, a consultant and director, three separate stints as the idea -- at the fda. of course, since he doesn't 17, he has been the commissioner, and as most people are aware, also a cancer survivor. sometime along the way, he managed to have three kids, but did very efficiently, because two of them are twins. >> my wife didn't efficiently. >> we can talk about that later. [laughter] >> i think the thing that has most intrigued me about scott gottlieb's tenure is that i was looking at people -- what people said when he was appointed, one of them was that he was a shill for pharmaceutical corporations. i think that he has impressed everybody, even those who do agree with them, with the integrity he is shown as commissioner, his ability to manage a large bureaucracy, and the fa